CRC Screening Using mSEPT9 (Methylated Septin 9) in Chinese Population
Ontology highlight
ABSTRACT: The purpose of this study is to evaluate the performance of the SEPT9 gene methylation assay in Colorectal cancer (CRC) high-risk population in Chinese hospitals using the opportunistic screening method. The trial plans to evaluate a Chinese domestic SEPT9 assay kit produced by BioChain (Beijing) Science and Technology Corporation, who is a close partner of Epigenomics AG, the producer for Epi proColon 2.0 CE.
DISEASE(S): Other Cancers,Adenomatous Polyps,Colonic Polyps,Other Disease/injury,Adenomatous Polyp Of Colon,Colorectal Cancer,Colorectal Neoplasms,Polyps
PROVIDER: 2197424 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA